Avalon globocare and qi diagnostics enter into definitive agreement to co-develop real-time cannabis breathalyzer for detecting potential impaired driving

Freehold, n.j., june 26, 2025 (globe newswire) -- avalon globocare corp. (“avalon” or the “company”) (nasdaq: albt), a developer of precision diagnostic consumer products, today announced that it entered into a definitive agreement with qi diagnostics limited (“qi diagnostics”), a nanosensor-based diagnostic technologies company, to co-develop a voc (volatile organic compound) nanosensor-based point-of-care cannabis breathalyzer.
ALBT Ratings Summary
ALBT Quant Ranking